Intervention Review

Tamoxifen for early breast cancer

  1. Mike J Clarke*

Editorial Group: Cochrane Breast Cancer Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 10 NOV 2000

DOI: 10.1002/14651858.CD000486.pub2

How to Cite

Clarke MJ. Tamoxifen for early breast cancer. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD000486. DOI: 10.1002/14651858.CD000486.pub2.

Author Information

  1. UK Cochrane Centre, Oxford, UK

*Mike J Clarke, UK Cochrane Centre, National Institute for Health Research, Summertown Pavilion, Middle Way, Oxford, OX2 7LG, UK. mclarke@cochrane.co.uk. clarkem2@TCD.ie.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 8 OCT 2008

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.